288 related articles for article (PubMed ID: 17187949)
1. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes.
Oliveira S; van Rooy I; Kranenburg O; Storm G; Schiffelers RM
Int J Pharm; 2007 Mar; 331(2):211-4. PubMed ID: 17187949
[TBL] [Abstract][Full Text] [Related]
2. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
Endoh T; Ohtsuki T
Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
[TBL] [Abstract][Full Text] [Related]
3. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
[TBL] [Abstract][Full Text] [Related]
4. Endosomal escape pathways for delivery of biologicals.
Varkouhi AK; Scholte M; Storm G; Haisma HJ
J Control Release; 2011 May; 151(3):220-8. PubMed ID: 21078351
[TBL] [Abstract][Full Text] [Related]
5. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
Wang XL; Xu R; Lu ZR
J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
[TBL] [Abstract][Full Text] [Related]
6. Cellular siRNA delivery mediated by a cell-permeant RNA-binding protein and photoinduced RNA interference.
Endoh T; Sisido M; Ohtsuki T
Bioconjug Chem; 2008 May; 19(5):1017-24. PubMed ID: 18442282
[TBL] [Abstract][Full Text] [Related]
7. Breaking down the barriers: siRNA delivery and endosome escape.
Dominska M; Dykxhoorn DM
J Cell Sci; 2010 Apr; 123(Pt 8):1183-9. PubMed ID: 20356929
[TBL] [Abstract][Full Text] [Related]
8. Photochemical internalization enhances silencing of epidermal growth factor receptor through improved endosomal escape of siRNA.
Oliveira S; Fretz MM; Høgset A; Storm G; Schiffelers RM
Biochim Biophys Acta; 2007 May; 1768(5):1211-7. PubMed ID: 17343820
[TBL] [Abstract][Full Text] [Related]
9. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(beta-amino esters).
Vandenbroucke RE; De Geest BG; Bonné S; Vinken M; Van Haecke T; Heimberg H; Wagner E; Rogiers V; De Smedt SC; Demeester J; Sanders NN
J Gene Med; 2008 Jul; 10(7):783-94. PubMed ID: 18470950
[TBL] [Abstract][Full Text] [Related]
10. Gene silencing activity of siRNA polyplexes based on biodegradable polymers.
Varkouhi AK; Lammers T; Schiffelers RM; van Steenbergen MJ; Hennink WE; Storm G
Eur J Pharm Biopharm; 2011 Apr; 77(3):450-7. PubMed ID: 21118719
[TBL] [Abstract][Full Text] [Related]
11. Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain.
Kim J; Lee SH; Choe J; Park TG
J Gene Med; 2009 Sep; 11(9):804-12. PubMed ID: 19569061
[TBL] [Abstract][Full Text] [Related]
12. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.
Sakurai Y; Hatakeyama H; Sato Y; Akita H; Takayama K; Kobayashi S; Futaki S; Harashima H
Biomaterials; 2011 Aug; 32(24):5733-42. PubMed ID: 21605898
[TBL] [Abstract][Full Text] [Related]
13. Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome.
Watanabe T; Umehara T; Yasui F; Nakagawa S; Yano J; Ohgi T; Sonoke S; Satoh K; Inoue K; Yoshiba M; Kohara M
J Hepatol; 2007 Dec; 47(6):744-50. PubMed ID: 17822798
[TBL] [Abstract][Full Text] [Related]
14. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape.
Bartz R; Fan H; Zhang J; Innocent N; Cherrin C; Beck SC; Pei Y; Momose A; Jadhav V; Tellers DM; Meng F; Crocker LS; Sepp-Lorenzino L; Barnett SF
Biochem J; 2011 Apr; 435(2):475-87. PubMed ID: 21265735
[TBL] [Abstract][Full Text] [Related]
15. RNA interference strategies as therapy for respiratory viral infections.
DeVincenzo JP
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S118-22. PubMed ID: 18820571
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
[TBL] [Abstract][Full Text] [Related]
17. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
[TBL] [Abstract][Full Text] [Related]
18. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
19. Transfection of "naked" siRNA results in endosomal uptake and metabolic impairment in cultured neurons.
Lingor P; Michel U; Schöll U; Bähr M; Kügler S
Biochem Biophys Res Commun; 2004 Mar; 315(4):1126-33. PubMed ID: 14985130
[TBL] [Abstract][Full Text] [Related]
20. Barriers to successful delivery of short interfering RNA after systemic administration.
White PJ
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1371-6. PubMed ID: 18565190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
